Back to search

Article

Exploring lncRNAs as Biomarkers for Monitoring Hepatocellular Carcinoma Immunotherapy Response

2026-07-28

Abstract excerpt

<title>Abstract</title> <p>Hepatocellular carcinoma (HCC) is one of the deadliest malignancies globally, characterised by a mean survival of 3 to 4 months upon late-stage diagnosis. While immunotherapy has shown success in managing HCC within specific patient subgroups, overall treatment response rates remain poor worldwide. In this study, we systematically investigated the role of long non-coding RNAs (lncRNAs)...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7d9e5380-c46c-5270-9199-b2b7047044e6
DOI
10.21203/rs.3.rs-10483008/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Exploring lncRNAs as Biomarkers for Monitoring Hepatocellular Carcinoma Immunotherapy ResponseDOI 10.21203/rs.3.rs-10483008/v1
Select a neighboring publication to make it the new centre.